aminocaproic acid has been researched along with Metastase in 6 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A life-threatening haemorrhagic cystitis, which occurred in a patient with metastatic prostatic carcinoma, was controlled with epsilon-aminocaproic acid (EACA) after conventional approaches to treatment failed." | 7.66 | Haemorrhagic cystitis treated with epsilon-aminocaproic acid. ( Aroney, RS; Dalley, DN; Levi, JA, 1980) |
| " pentoxifylline (Px) (which also were found to release PgI2 and t-PA) inhibited human tumor implant induced angiogenesis and reduced spontaneous metastases in 3 transplantable murine tumors (Furth-Columbia Wilms' tumor in Furth-Wistar rats, C-1300 neuroblastoma in A/J mice and HM-Kim mammary carcinoma in Wistar rats) but not in the NIH adenocarcinoma in Balb/c mice." | 3.68 | Studies on tumor induced angiogenesis. ( Ambrus, CM; Ambrus, JL; Forgach, P; Halpern, J; Niswander, P; Sayyid, S; Stadler, S; Toumbis, C, 1992) |
| "A life-threatening haemorrhagic cystitis, which occurred in a patient with metastatic prostatic carcinoma, was controlled with epsilon-aminocaproic acid (EACA) after conventional approaches to treatment failed." | 3.66 | Haemorrhagic cystitis treated with epsilon-aminocaproic acid. ( Aroney, RS; Dalley, DN; Levi, JA, 1980) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (83.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| CLIFFTON, EE | 2 |
| AGOSTINO, D | 2 |
| BOSMAN, G | 1 |
| Aroney, RS | 1 |
| Dalley, DN | 1 |
| Levi, JA | 1 |
| Ambrus, JL | 1 |
| Ambrus, CM | 1 |
| Forgach, P | 1 |
| Stadler, S | 1 |
| Halpern, J | 1 |
| Sayyid, S | 1 |
| Niswander, P | 1 |
| Toumbis, C | 1 |
| Williams, EC | 1 |
6 other studies available for aminocaproic acid and Metastase
| Article | Year |
|---|---|
EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES.
Topics: Aminocaproates; Aminocaproic Acid; Blood; Carcinosarcoma; Enzyme Inhibitors; Fibrinolysin; Fibrinoly | 1964 |
THE EFFECTS OF FIBRIN FORMATION AND ALTERATIONS IN THE CLOTTING MECHANISM ON THE DEVELOPMENT OF METASTASES.
Topics: Aminocaproates; Aminocaproic Acid; Animals; Aprotinin; Blood Coagulation; Carcinoma 256, Walker; Car | 1965 |
[FIBRINOLYSIS; CLINICAL APPLICATIONS].
Topics: Aminocaproates; Aminocaproic Acid; Drug Therapy; Fibrinolysis; Hemorrhagic Disorders; Humans; Male; | 1964 |
Haemorrhagic cystitis treated with epsilon-aminocaproic acid.
Topics: Aminocaproates; Aminocaproic Acid; Antineoplastic Agents; Cystitis; Hemorrhage; Humans; Male; Middle | 1980 |
Studies on tumor induced angiogenesis.
Topics: Adenocarcinoma; Aminocaproic Acid; Animals; Cornea; Ditiocarb; Humans; Kidney Neoplasms; Macaca; Mam | 1992 |
Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
Topics: Adolescent; alpha-2-Antiplasmin; Aminocaproic Acid; Blood Coagulation Disorders; Child; Disseminated | 1989 |